$12.60
-0.02-0.16%
At close: May 19, 5:00 PM EST
$12.55
-0.05-0.40%
After Hours: May 18, 4:22 PM EST
Pharming Group Earnings Estimates
PHARNASDAQ
Pharming Earnings Estimates, EPS & Revenue | NASDAQ:PHAR
Pharming (PHAR) is scheduled to report Q2 earnings on July 30, 2026. Analysts estimate EPS of $0.09 and quarterly revenue of $101.15M.
In the most recent quarter (Q1), Pharming reported EPS of $-0.07, missing estimates of $0.01 by 8.00%. Revenue came in at $72.40M, missing the estimate of $92.40M by 0.22%.
Over the last 4 quarters, Pharming has averaged an EPS surprise of 3.55% and a revenue surprise of 0.18%.
Earnings Date
Jul 30
EPS Estimate
$0.090
Quarterly Revenue Estimate
$101.15M
Annual Revenue
(as of Mar 31)
(as of Mar 31)
$369.49M
Pharming Earnings History
Analyze the earnings history of Pharming using advanced sorting and filters.
Loading calendar...
Pharming (PHAR) Earnings Per Share
The chart below shows Pharming's reported EPS compared to analyst estimates over recent quarters.
Pharming (PHAR) Revenue
The chart below shows Pharming's reported revenue compared to analyst estimates over recent quarters.
FAQ
When is Pharming (NASDAQ:PHAR) reporting earnings?
Pharming (PHAR) is scheduled to report earnings on July 30, 2026. The last reported earnings were for reported on May 7, 2026 for Q1.
What were the latest earnings per share (EPS) for Pharming (NASDAQ:PHAR)?
The Actual EPS was $-0.07, which missed the estimate of $0.01.
What were Pharming’s (NASDAQ:PHAR) revenues?
The Actual Revenue was $72.40M, which missed the estimate of $92.40M.
